Albuminuria and chronic kidney disease in association with the metabolic syndrome.

Toshiharu Ninomiya, Yutaka Kiyohara

研究成果: Contribution to journalReview article査読

27 被引用数 (Scopus)

抄録

Chronic kidney disease is a worldwide public health problem because it is an important risk factor for cardiovascular disease and premature death. The metabolic syndrome, which is characterized by abdominal obesity, high blood pressure, impaired glucose tolerance, and dyslipidemia, is also an increasingly common disorder and a major risk factor for diabetes and cardiovascular disease. A close association has been found between the metabolic syndrome and the risk for developing renal impairment, clinically expressed in the form of microalbuminuria or chronic kidney disease. Several potential mechanisms, including insulin resistance, renal atherosclerosis, and inflammation, induce the deterioration of renal function. Despite the close association between the metabolic syndrome and renal impairment, it is still unclear whether and to what extent treating the metabolic syndrome will prevent renal impairment. A clinical trial is needed to clarify whether the effect of preventing and treating metabolic syndrome components will result in improved renal prognosis.

本文言語英語
ページ(範囲)104-107
ページ数4
ジャーナルJournal of the cardiometabolic syndrome
2
2
DOI
出版ステータス出版済み - 2007

All Science Journal Classification (ASJC) codes

  • 内科学
  • 内分泌学、糖尿病および代謝内科学
  • 循環器および心血管医学

フィンガープリント

「Albuminuria and chronic kidney disease in association with the metabolic syndrome.」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル